Invirase

   
Google
 
Web NewDrugInformation.com

Invirase


Drug - Invirase
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Saquinavir Mesylate
Multiple ingredients are in alphabetical order.

Strength - EQ 200MG BASE
The potency of the active ingredient(s), Saquinavir Mesylate. May repeat for multiple part products.

Applicant - HLR
The firm name holding legal responsibility for Invirase. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020628
The FDA assigned number to Invirase. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Invirase. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 6, 1995
The date Invirase was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Invirase. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Invirase is in. Format is RX, OTC, DISCN.

Applicant Full Name - Hlr Technology
The full name of the firm holding legal responsibility for the new application of Invirase.

Invirase